Mary Hobbs-Maluccio, MD
Surgical Oncology · Metairie, LANPI 1477505071
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Advanced Accelerator Applications accounts for 73.3% of it on its own, with 51 other manufacturers making up the rest. Reporting peaked in 2019 at $29,591 and has fallen 88.3% since, to $3,449 in 2025. Among surgical oncology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $215.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Advanced Accelerator Applications$30K
- Histosonics, Inc.$6K
- Johnson & Johnson$392
- Exelixis Inc.$390
- Ipsen Biopharmaceuticals, Inc$297
- Covidien LP$290
- plus $4K from 46 others
Across 8 payments — averaging $24,068 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$163K
- Novartis$28K
- Novartis Pharma AG$841
What the payments were for
- Speaking & faculty fees$24,20060%
- Travel & lodging$10,86727%
- Food & beverage$5,53114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lutathera$29,246
- VISTASEAL$230
- HemoBlast Bellows$152
- HEMOBLAST$140
- Versajet$127
- Sylvant$126
- Signia$123
- Cabometyx$122
- ONIVYDE$121
- ECHELON ENDOPATH$120
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$119
- INTERA$115
- PYLARIFY$104
How this compares
$40,598 in reported general payments places this provider in the 95th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 16 | $12,069 |
| Octreotide Acetate | 18 | $4,544 |
| Celecoxib | 16 | $950 |
| Sucralfate | 12 | $367 |
| Pantoprazole Sodium | 26 | $319 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 26 | $285 |
| Insulin SyringeSyringe And Needle,insulin,1ml | 12 | $196 |
| Metoclopramide Hcl | 22 | $102 |
| Ondansetron Hcl | 13 | $82 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $91 | $12,06916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 26 surgical oncology providers in Louisiana.
Other surgical oncology in Metairie
- Emery MinnardGretna$183K
- Terry LairmoreShreveport$13K
- Peter BostickBaton Rouge$7K
- Nathan BoltonNew Orleans$6K
- Lindsey FauveauBaton Rouge$4K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
- Amy RivereNew Orleans$4K
- Omeed MoavenNew Orleans$3K
- Nicole WalkerNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.